After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
So far 4.21 crore patients have been treated under the Ayushman Bharat Pradhan Mantri Jan Arogya
Did Trump threaten not to trade for a ceasefire? India rejects the US President's statement
A ceasefire has been declared between India and Pakistan. A ceasefire was agreed between the two
'Revdi culture' is making political headlines these days. 'Revdi Culture' means free offers
Hariyali Teej 2023: Hariyali Teej has special significance in Hinduism. The festival of Hariyali
Controversy has now arisen in Canada regarding the Swastika, the sacred symbol of Hindus. A bill
IND vs SA: 'One of the 10 best innings in Indian Test history', Gavaskar praised KL Rahul's century
Lokesh Rahul's brilliant century in the first Test match against South Africa was praised by the
Pakistan's Foreign Minister Bilawal Bhutto has again given a controversial statement. He said tha
Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the
Slow wind speeds and adverse weather conditions have turned Delhi into a gas chamber. For the thi
JAC 9th Result 2023: JAC released the 9th result, you can check your result by clicking here
Jharkhand Academic Council JAC has declared the 9th class result. This time a total of 97.8 perce
